US Broker Ratings

PACS Group, Inc. (PACS) Stock Analysis: A Promising 15.71% Upside in the Healthcare Sector

PACS Group, Inc. (PACS), a significant player in the healthcare sector, specifically within the medical care facilities industry, has been making waves on the stock market..

Twist Bioscience Corporation (TWST) Stock Analysis: Assessing the Upside in Synthetic DNA Innovation

Twist Bioscience Corporation (NASDAQ: TWST) is carving out a significant niche in the healthcare sector, particularly within diagnostics and research. As a pioneering company in synthetic..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Unpacking a Potential 36% Upside for Investors

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) presents an intriguing opportunity for investors interested in the biotechnology sector. With a market capitalization of $1.57 billion, this Cambridge, Massachusetts-based..

Adaptive Biotechnologies Corporation (ADPT) Stock Analysis: Exploring a 31.51% Upside in the Booming Biotech Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) has been making waves in the biotechnology sector, drawing attention from investors with its innovative approach to immune medicine and a..

CG Oncology, Inc. (CGON) Investor Outlook: Exploring a 55% Potential Upside in the Biotech Sector

CG Oncology, Inc. (NASDAQ: CGON) has captured the attention of investors with its significant potential upside, as reflected in its average target price of $79.21. As..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: Exploring a Potential 48.70% Upside

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a prominent player in the biotechnology sector, is captivating investor interest with its robust pipeline and promising market potential. Headquartered in..

Supernus Pharmaceuticals, Inc. (SUPN): Investor Outlook on CNS Drug Innovator with 19.56% Upside Potential

Investors looking to capitalize on the burgeoning healthcare sector might find Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) an intriguing prospect. With its focus on developing and commercializing..

Immunovant, Inc. (IMVT) Stock Analysis: Potential Upside of 47.10% Makes It a Biotech to Watch

Immunovant, Inc. (NASDAQ: IMVT), a New York-based clinical-stage biotech company, is capturing investor attention with its strategic focus on monoclonal antibodies aimed at treating autoimmune diseases...

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Unveiling a 40.86% Potential Upside in the Biotech Sector

Travere Therapeutics, Inc. (NASDAQ: TVTX) stands as a compelling player in the biotechnology industry, focusing on developing therapies for rare kidney and metabolic diseases. With its..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring a Potential 20.85% Upside in the Biotech Sector

MoonLake Immunotherapeutics (NASDAQ: MLTX), a burgeoning player in the biotechnology industry, has captured the attention of investors with its innovative approach to treating inflammatory diseases. Headquartered..

Evotec SE (EVO) Stock Analysis: Unveiling a 53.82% Potential Upside Amidst Current Challenges

Evotec SE (EVO), a prominent player in the healthcare sector, operates within the specialty and generic drug manufacturing industry. Headquartered in Hamburg, Germany, Evotec SE is..

Amicus Therapeutics (FOLD) Stock Analysis: Navigating Growth in Rare Disease Biotech

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is garnering attention in the biotechnology sector with its strategic focus on rare diseases, a niche that promises both potential growth..

HUTCHMED (China) Limited (HCM): Investor Outlook on a Potential 41.74% Upside

HUTCHMED (China) Limited (NASDAQ: HCM) presents a compelling opportunity for investors seeking exposure to the dynamic healthcare sector, particularly in the realm of innovative cancer treatments...

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: A 30% Upside Potential in the Biotech Sector

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a prominent player in the biotechnology sector, has been capturing investor attention with its remarkable growth trajectory and promising pipeline of..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Biotech Gem with 14% Upside Potential

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is making waves in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $6.02 billion, this U.S.-based..

Acadia Healthcare (ACHC) Stock Analysis: Evaluating a 41% Upside Potential Amidst Strong Buy Ratings

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) presents itself as an intriguing opportunity for investors seeking exposure in the healthcare sector, particularly within the specialized realm of..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a 106% Upside Potential Amid Healthcare Industry Dynamics

GoodRx Holdings, Inc. (NASDAQ: GDRX), a prominent player in the healthcare sector, is currently capturing investor attention with a substantial potential upside of over 106%. As..

Schrodinger, Inc. (SDGR) Stock Analysis: Unveiling an 83.82% Upside Potential

For investors with an eye on innovation within the healthcare sector, Schrodinger, Inc. (NASDAQ: SDGR) presents an intriguing opportunity. The New York-based company, with a market..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 29.78% Upside Potential in the Diagnostics Sector

Veracyte, Inc. (NYSE: VCYT) stands out in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $2.9 billion, this South..

National HealthCare Corporation (NHC) Stock Analysis: A Closer Look at Strong Revenue Growth Amidst Lack of Analyst Ratings

National HealthCare Corporation (NYSE: NHC), a prominent player in the healthcare sector, operates a diversified portfolio of medical care facilities across the United States. This company,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds